| Watchman | ACP 2 | All | p Value |
---|---|---|---|---|
Success rate, n (%) | 21 (95.5) | 15 (100) | 36 (97.3) | 0.403 |
Complete ostial occlusion (i.e., gap < 5 mm), n (%) | 20 (90.9) | 14 (93.3) | 34 (91.9) | 0.791 |
Positioning attempts, n (IQR) | 2.5 (1.75–3) | 2 (1.5–5) | 2 (2–3) | 0.555 |
Changes of device size, n (IQR) | 1 (1–1) | 1 (1–2) | 1 (1–1) | 0.169 |
Final device size, mm (IQR) | 24 (21–27) | 25 (22–30) | 24 (22–27) | - |
Duration, min. (IQR) | 122.5 (75–136.25) | 100 (80–110) | 110 (76–135) | 0.069 |
Fluoroscopy time, min. (IQR) | 11.7 (7.4–16.8) | 12.7 (9.5–17.7) | 12.4 (8.5–16.9) | 0.244 |
Reference dose, Gy*cm2 (IQR) | 80.5 (45.75–103.25) | 62 (52–89) | 64 (49–96) | 0.842 |
Amount of contrast agent, ml (IQR) | 165 (130–202.25) | 140 (110–180) | 157 (110–195) | 0.833 |
LAA configuration, n (%) | Â | Â | Â | Â |
 - Chicken-wing | 14 (63.6) | 11 (73.3) | 25 (67.6) | 0.536 |
 - Windsock | 3 (13.6) | 1 (6.7) | 4 (10.8) | 0.503 |
 - Broccoli | 4 (18.2) | 3 (20) | 7 (18.9) | 0.890 |
 - Tub | 1 (4.5) | 0 (0) | 1 (2.7) | 0.403 |
Number of lobi, n (%) | Â | Â | Â | Â |
 - 1 | 4 (18.2) | 3 (20) | 7 (18.9) | 0.890 |
 - 2 | 13 (59.1) | 10 (66.7) | 23 (62.2) | 0.641 |
 - 3 | 1 (4.5) | 0 (0) | 1 (2.7) | 0.403 |
 - Multi | 4 (18.2) | 2 (13.3) | 6 (16.2) | 0.694 |
Days on ICU/IMC, n (IQR) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 0.327 |
Post-procedural days in hospital, n (IQR) | 3 (2.25–4) | 4 (2.75–5.25) | 4 (2.75–5) | 0.341 |